News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sucampo Pharmaceuticals, Inc. (SCMP) Appoints Kei Tolliver to Board of Directors


5/29/2013 7:36:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (“Sucampo”) today announced that Kei S. Tolliver, executive vice president at S&R Technology Holdings, LLC, was elected to its board of directors at the annual shareholder meeting on May 22, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES